Cargando…

Safety Consequences of Off-Label Drugs Used for COVID-19

Detalles Bibliográficos
Autor principal:	Dasgupta, Nabarun
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer International Publishing 2021
Materias:	Commentary
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7934123/ https://www.ncbi.nlm.nih.gov/pubmed/33666902 http://dx.doi.org/10.1007/s40264-021-01056-0

Ejemplares similares

Off-label drugs use in pediatric palliative care
por: De Zen, Lucia, et al.
Publicado: (2018)

Off-label use of drugs in regional anesthesia: A need for setting up policies
por: Singh, Saru, et al.
Publicado: (2017)

In-/off-label use of biologic therapy in systemic lupus erythematosus
por: Gatto, Mariele, et al.
Publicado: (2014)

Invited Commentary: Drug Checking for Novel Insights Into the Unregulated Drug Supply
por: Dasgupta, Nabarun, et al.
Publicado: (2021)

Research led by people who use drugs: centering the expertise of lived experience
por: Salazar, Zach R., et al.
Publicado: (2021)

Thinking Systematically About the Off-Label Use of Cancer Drugs and Combinations for Patients Who Have Exhausted Proven Therapies
por: Mailankody, Sham, et al.
Publicado: (2016)

Off-label drug promotion and the ephemeral line between marketing and education
por: Krause, Joan H.
Publicado: (2015)

COVID-19 and off label use of drugs: an ethical viewpoint
por: Shojaei, Amirahmad, et al.
Publicado: (2020)

Long term consequences of COVID-19
por: Berenguera, Anna, et al.
Publicado: (2021)

Methylphenidate off-label use and safety
por: Trenque, Thierry, et al.
Publicado: (2014)

Multiple drugs: COVID-19 infection and off-label use: case report
Publicado: (2021)

Multiple drugs: COVID-19 and off-label use: 22 case reports
Publicado: (2021)

Multiple drugs: Pancytopenia, COVID-19 and off-label use: case report
Publicado: (2020)

Multiple drugs: COVID-19 and off-label use: 2 case reports
Publicado: (2020)

Cardiac safety of off-label COVID-19 drug therapy: a review and proposed monitoring protocol
por: Naksuk, Niyada, et al.
Publicado: (2020)

Medicolegal consequences of altered COVID-19 vaccine administration
por: Muir, Gordon, et al.
Publicado: (2021)

Off-Label Use vs Off-Label Marketing of Drugs: Part 1: Off-Label Use—Patient Harms and Prescriber Responsibilities
por: Van Norman, Gail A.
Publicado: (2023)

MedDRA Labeling Groupings to Improve Safety Communication in Product Labels
por: Große-Michaelis, Ilona, et al.
Publicado: (2022)

Cladribine: Off-label disease modification for people with multiple sclerosis in resource-poor settings?
por: Mao, Zhifeng, et al.
Publicado: (2018)

Rectal use of levetiracetam: best practice report for a stepwise approach for sustainable off-label decision making and treatment
por: Rémi, Constanze, et al.
Publicado: (2023)

Multiple drugs: Off-label use and failure to respond in COVID-19: case report
Publicado: (2022)

Ethical review of off-label drugs during the COVID-19 pandemic
por: Li, Qiu-Yu, et al.
Publicado: (2022)

Multiple drugs: COVID-19 infection, drug induced psychosis and off-label use: case report
Publicado: (2021)

Automated Detection of Off-Label Drug Use
por: Jung, Kenneth, et al.
Publicado: (2014)

Off-label drugs for obesity
por: Morgan, Andy, et al.
Publicado: (2022)

Off-Label and Off-NCCN Guidelines Uses of Antineoplastic Drugs in China
por: WANG, Weilan, et al.
Publicado: (2013)

COVID-19: Challenges and its consequences for rural health care in India
por: Kumar, Anant, et al.
Publicado: (2020)

Evaluating potential unintended consequences of COVID-19 vaccine mandates and passports
por: Smith, Maxwell J
Publicado: (2022)

Guiding axes for drug safety management of pharmacovigilance centres during the COVID-19 era
por: Ferreira-da-Silva, Renato, et al.
Publicado: (2021)

Multiple drugs: Various toxicities, off-label use and no response to off-label therapy: case report
Publicado: (2021)

Protecting Canada’s children from the consequences of the fourth wave of the COVID-19 pandemic
por: Freedman, Stephen B., et al.
Publicado: (2021)

Early marriage and teenage pregnancy: The unspoken consequences of COVID-19 pandemic in Nigeria
por: Musa, Shuaibu Saidu, et al.
Publicado: (2021)

Consequences of COVID-19 crisis for persons with HIV: the impact of social determinants of health
por: Waterfield, Kristie C., et al.
Publicado: (2021)

COVID-19 pandemic response fatigue in Africa: causes, consequences, and counter-measures
por: Ilesanmi, Olayinka Stephen, et al.
Publicado: (2020)

Multiple drugs: COVID-19 infection, lack of efficacy and off-label use: case report
Publicado: (2021)

Multiple drugs: Off label use, pulmonary aspergillosis and COVID-19 pneumonitis: case report
Publicado: (2021)

Multiple drugs: Lack of efficacy in COVID-19 pneumonia and off label use: case report
Publicado: (2021)

Multiple drugs: COVID-19 pneumonia, off-label use and lack of efficacy: case report
Publicado: (2021)

Multiple drugs: COVID-19 pneumonia secondary to hypogammaglobulinaemia and off-label use: case report
Publicado: (2022)

Evaluation of off-label medication use and drug safety in a pediatric intensive care unit
por: Lee, Soojin, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_29vu5lifcrjo5tidahuur0s8at